A Nurse-Led Digital Coaching Program to Improve Blood Sugar Control in Adults With Type 2 Diabetes
NCT07916584, Not applicable, Not yet recruiting, Alexandria University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | A Nurse-Led Digital Coaching Program to Improve Blood Sugar Control in Adults With Type 2 Diabetes | ClinicalTrials.gov |
| NCT number | NCT07916584 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 160 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Alexandria University | ClinicalTrials.gov |
| Conditions | Type 2 Diabetes Mellitus | ClinicalTrials.gov |
| Interventions | ChronoCoach, Usual diabetes care | ClinicalTrials.gov |
| First posted | 2026-11-04 | ClinicalTrials.gov |
| Last updated | 2026-11-04 | ClinicalTrials.gov |
Registered outcomes 6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Glycated hemoglobin (HbA1c) | Baseline and 3 months | HbA1c (%) measured by an accredited clinical laboratory. The between-group difference in 3-month HbA1c, adjusted for baseline HbA1c. Lower values indicate better glycemic control. | ClinicalTrials.gov |
| Secondary | Diabetes self-care behaviours - Summary of Diabetes Self-Care Activities (SDSCA) | Baseline, 3 months and 6 months | The validated Arabic version of the Summary of Diabetes Self-Care Activities measures how many days in the past 7 days the participant carried out self-care activities. Results are reported separately for five subscales: diet, exercise, blood glucose testing, foot care, and medication taking. Each subscale score is the mean number of days per week across its items, with a minimum of 0 and a maximum of 7. Higher scores mean better self-care. | ClinicalTrials.gov |
| Secondary | Diabetes self-efficacy - Diabetes Management Self-Efficacy Scale (DMSES) | Baseline, 3 months and 6 months | The validated Arabic version of the 20-item Diabetes Management Self-Efficacy Scale measures how confident the participant feels about carrying out diabetes self-management tasks. Each item is rated from 0 ("cannot do at all") to 10 ("certainly can do"). The total score ranges from 0 to 200. Higher scores mean greater self-efficacy, which is a better outcome. | ClinicalTrials.gov |
| Secondary | Health-related quality of life - WHOQOL-BREF | Baseline, 3 months and 6 months | The validated Arabic version of the 26-item World Health Organization Quality of Life - Brief Version asks about the participant's quality of life over the past 2 weeks. Each item is rated on a 5-point scale from 1 to 5. The instrument gives four domain scores: physical health (7 items) psychological (6 items) social relationships (3 items) environment (8 items) Each domain score is converted to a 0-100 scale using the standard WHO scoring method, so the minimum is 0 and the maximum is 100. Higher scores mean better quality of life. Two further single items, on overall quality of life and general health, are scored separately from 1 to 5, where higher scores are better. Results are reported for each domain separately, not as a total score. | ClinicalTrials.gov |
| Secondary | Family involvement in diabetes self-management - Family/Friend Involvement in Adults' Diabetes (FIAD) | Baseline, 3 months and 6 months | The Arabic version (translated and back-translated) of the Family/Friend Involvement in Adults' Diabetes scale measures how family members and friends were involved in the participant's diabetes self-care over the past 30 days. It has two subscales: Helpful involvement (9 items): higher scores mean more helpful involvement, which is a better outcome. Harmful involvement (7 items): higher scores mean more harmful involvement, which is a worse outcome. Each item is rated from 1 to 5, and each subscale score is the mean of its items, giving a minimum of 1 and a maximum of 5. The two subscales are reported separately, not combined into a total. In this sample, Cronbach's alpha was 0.87 for the helpful subscale and 0.72 for the harmful subscale. | ClinicalTrials.gov |
| Secondary | Participant satisfaction - Client Satisfaction Questionnaire (CSQ-8) | 3 months | The 8-item Client Satisfaction Questionnaire measures satisfaction with the ChronoCoach program. Each item is rated from 1 to 4, and the items are summed for a total score with a minimum of 8 and a maximum of 32. Higher scores mean greater satisfaction, which is a better outcome. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 7
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)